Immunosuppressive properties of thalidomide. Inhibition of in vitro lymphocyte proliferation alone and in combination with cyclosporine or FK506.
Keenan
R J
RJ
Department of Surgery, University of Pittsburgh, Pennsylvania.
Eiras
G
G
Burckart
G J
GJ
Stuart
R S
RS
Hardesty
R L
RL
Vogelsang
G
G
Griffith
B P
BP
Zeevi
A
A
D000001:Calcimycin; D002478:Cells, Cultured; D016572:Cyclosporine / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D004347:Drug Interactions; D006801:Humans; D007108:Immune Tolerance / Q000187:drug effects*; D066298:In Vitro Techniques; D008213:Lymphocyte Activation / Q000187:drug effects; D007959:Lymphocyte Culture Test, Mixed; D010835:Phytohemagglutinins; D016559:Tacrolimus / Q000494:pharmacology; D013792:Thalidomide / Q000494:pharmacology*
D010835:Phytohemagglutinins; D000001:Calcimycin; D013792:Thalidomide; D016572:Cyclosporine; D016559:Tacrolimus